A Study of Avapritinib in Pediatric Patients With Relapsed or Refractory Solid Tumors With a Mutation in KIT or PDGFRA
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- CNS Tumor
- Relapsed Solid Neoplasm
- Solid Tumor, Unspecified, Child
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 2 years and 17 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04773782
- Collaborators
- Not Provided
- Investigators
- Not Provided